Xiangzhu Wang
Associate Director Medicinal Chemistry@ Kumquat Biosciences Inc.
View Xiangzhu Wang's Email
View Xiangzhu Wang's Email & Phone
Real-Time AI Research
0 search queries left
FlashIntel GPT
Hello! I'm FlashIntel GPT, your personal AI search assistant. Feel free to ask me anything about Xiangzhu Wang, and I'll do my best to assist you.
You

Tell me more about Xiangzhu Wang?

FlashIntel GPT

Xiangzhu Wang is a dedicated professional with over 20 years of experience in small molecule drug discovery. He has worked on various therapeutic areas such as oncology, antiviral HCV, autoimmune disease, and Complement Factor D mediated diseases. Xiangzhu has a strong focus on high-quality design of drug-like molecules and executing organic chemistry. He has advanced to phase II human clinical studies and has held positions at Kumquat Biosciences Inc., Eternity Bioscience, Achillion Pharmaceuticals, and LSDG Roofing and Construction.
For inquiries about Phone Number and Email, please click here Unlock Contact

Research Details
Skills & Insights
Colleagues

Emails and Phone Numbers

@lsdgroofing.com
@kumquatbio.com
@lsdgroofing.com
@kumquatbio.com
@kumquatbio.com
View Emails and Phone Numbers
10 free lookups per month

About

Dedicated to small molecule drug discovery for 15+ years, I have driven medicinal chemistry efforts on multiple therapeutic areas such as oncology, antiviral HCV, autoimmune disease and Complement Factor D mediated disease. Through excellence in high quality design of drug-like molecules and execution of organic chemistry, drug candidates such as Sovaprevir (ACH-1625), Neceprevir (ACH-2684) and Odalasvir (ACH-3102) were advanced to phase II human clinical studies.

Work Experience

3033 Science Park Rd, San Diego, California, 92121, US

Biotechnology Research

45
Show More

Xiangzhu Wang's Professional Milestones

  • Associate Director Medicinal Chemistry (2019-09-01~): Building a strong team to deliver high-quality pharmaceutical chemistry products on time and within budget.
  • Sr. Principal Investigator, Medicinal Chemistry (2018-04-01~2019-09-01): Conducted extensive research to identify potential therapeutic pathways and improve patient outcomes.
Show More

Education

National Cancer Institute (NCI)
National Cancer Institute (NCI)2001-2003
Show More